By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


OpGen, Inc. 

505 South Rosa Road
Suite 151
Madison  Wisconsin  53719  U.S.A.
Phone: 608-441-8100 Fax:




Company News
District Of Columbia Hospital Association Chooses OpGen (OPGN) To Create Citywide Effort To Track Multidrug-Resistant Bacteria 11/18/2015 10:47:32 AM
OpGen (OPGN) Reports Third Quarter Financial Results And Provides Business Update 11/13/2015 8:05:37 AM
Data Show “Super Bug” Surveillance System Based On OpGen (OPGN)’s Acuitas Resistome Test Can Identify Potential Outbreaks In Hospitals And Improve Infection Control 10/12/2015 7:33:47 AM
OpGen (OPGN) To Present Data Showing Acuitas Tests Are Effective Tools For Investigating Transmission Of "Super Bugs" 9/22/2015 7:59:08 AM
OpGen (OPGN) Reports Second Quarter Financial Results And Provides Business Update 8/14/2015 10:44:35 AM
OpGen (OPGN) Announces Timing For Second Quarter Financial Results And Conference Call 8/5/2015 10:18:24 AM
OpGen (OPGN) Closes $6 Million Financing With Merck GHI To Expand Infectious Disease Diagnostic Testing Capabilities 7/14/2015 7:27:16 AM
Fluidigm Corporation And OpGen (OPGN) Enter Into Strategic Agreement To Develop Multi-Drug Resistance Testing Kits And Equipment 7/13/2015 10:12:07 AM
OpGen (OPGN) Reports First Quarter Financial Results And Provides Business Update 6/18/2015 7:31:46 AM
OpGen (OPGN) Releases Next-Generation Molecular Testing And Bioinformatics Solution For Combating Multi-Drug Resistant Infections 6/2/2015 10:54:04 AM